Average Co-Inventor Count = 8.47
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (34 from 123 patents)
2. Eli Lilly and Company (10 from 4,442 patents)
3. Otsuka Pharmaceutical Company, Limited (3 from 845 patents)
4. Tularik Limited (3 from 126 patents)
5. Astrazeneca Ab (2 from 1,500 patents)
6. Cisco Technology, Inc. (1 from 20,333 patents)
7. Protherics Molecular Design Limited (1 from 1 patent)
52 patents:
1. 11939321 - Benzolactam compounds as protein kinase inhibitors
2. 11001575 - Benzolactam compounds as protein kinase inhibitors
3. 10519137 - Pyrazolyl quinoxaline kinase inhibitors
4. 10457669 - Benzolactam compounds as protein kinase inhibitors
5. 10272087 - Pteridines as FGFR inhibitors
6. 10052320 - Substituted quinoxalines as FGFR kinase inhibitors
7. 9914719 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90
8. 9856236 - Substituted quinoxalines as FGFR kinase inhibitors
9. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
10. 9617248 - Bicyclic heterocycle compounds and their uses in therapy
11. 9617283 - Bicyclic heterocycle compounds and their uses in therapy
12. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
13. 9447098 - Pteridines as FGFR inhibitors
14. 9303029 - Substituted quinoxalines as FGFR kinase inhibitors
15. 9290478 - Substituted quinoxalines as FGFR kinase inhibitors